Phase Ib extension study of eribulin mesylate in combination with carboplatin in patients with chemotherapy-naive advanced non-small cell lung cancer (NSCLC).
Harry Raftopoulos
Research Funding - Eisai
Joseph Aisner
Research Funding - Cancer Institute of New Jersey, UMDNJ
Kirushna Kumar
Research Funding - Eisai
Sanjay Goel
Research Funding - Eisai
Christian Dittrich
Consultant or Advisory Role - Eisai
Research Funding - Eisai
Minish Jain
No relevant relationships to disclose
Prashanth Gopalakrishna
Employment or Leadership Position - Eisai
Paloma Salazar
Employment or Leadership Position - Eisai
Beverley Jones
Consultant or Advisory Role - Eisai
Daniel Peter Petrylak
Research Funding - Eisai